Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NISCH | Q9Y2I1 | 14/20 | 0.81 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8887144 | 0.88 | NISCH (0.66) | NISCH | |
| SCHEMBL3394014 | 0.86 | NISCH (0.65) | NISCH | |
| SCHEMBL16863098 | 0.86 | NISCH (0.76) | NISCH | |
| SCHEMBL1626317 | 0.86 | NISCH (1.00) | NISCH | |
| SCHEMBL80782 | 0.86 | NISCH (0.62) | NISCH | |
| SCHEMBL2949149 | 0.86 | NISCH (0.62) | NISCH | |
| SCHEMBL1882130 | 0.86 | NISCH (0.62) | NISCH | |
| SCHEMBL4066263 | 0.86 | NISCH (0.62) | NISCH | |
| SCHEMBL4818139 | 0.86 | NISCH (0.62) | NISCH | |
| SCHEMBL8194068 | 0.85 | NISCH (0.77) | NISCH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3087216-B1 | BIS-IMIDAZOLINE COMPOUNDS AS CORROSION INHIBITORS AND PREPARATION THEREOF | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-10-10 | — | — | EP | disclosed |
| US-20160319442-A1 | BIS-IMIDAZOLINE COMPOUNDS AS CORROSION INHIBITORS AND PREPARATION THEREOF | DOW INTERNATIONAL TECHNOLOGY CORPORATION | 2016-11-03 | — | — | US | disclosed |
| US-5210152-A | Metal oxide vulcanization in the presence of amidine compounds | BAYER AKTIENGESELLSCHAFT (DE) | 1993-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160319442-A1 | BIS-IMIDAZOLINE COMPOUNDS AS CORROSION INHIBITORS AND PREPARATION THEREOF | SOD1, FHIT, TFPI | NISCH 49/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.